Literature DB >> 29565013

Questionable efficacy of the rVSV-ZEBOV Ebola vaccine.

Wolfram G Metzger1, Sarai Vivas-Martínez2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29565013     DOI: 10.1016/S0140-6736(18)30560-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge.

Authors:  Drishya Kurup; Christine R Fisher; Todd G Smith; Tiago Abreu-Mota; Yong Yang; Felix R Jackson; Nadia Gallardo-Romero; Richard Franka; Victor Bronshtein; Matthias J Schnell
Journal:  J Infect Dis       Date:  2019-09-26       Impact factor: 5.226

2.  Prevention of Ebola virus disease through vaccination: where we are in 2018.

Authors:  Yves Lévy; Clifford Lane; Peter Piot; Abdul Habib Beavogui; Mark Kieh; Bailah Leigh; Seydou Doumbia; Eric D'Ortenzio; Claire Lévy-Marchal; Jerome Pierson; Deborah Watson-Jones; Vinh-Kim Nguyen; Heidi Larson; Julia Lysander; Christine Lacabaratz; Rodolphe Thiebaut; Augustin Augier; David Ishola; Stephen Kennedy; Geneviève Chêne; Brian Greenwood; James Neaton; Yazdan Yazdanpanah
Journal:  Lancet       Date:  2018-08-10       Impact factor: 79.321

Review 3.  Lassa virus diversity and feasibility for universal prophylactic vaccine.

Authors:  Igor S Lukashevich; Slobodan Paessler; Juan Carlos de la Torre
Journal:  F1000Res       Date:  2019-01-31

4.  Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.

Authors:  Evelyn M Covés-Datson; Julie Dyall; Lisa Evans DeWald; Steven R King; Derek Dube; Maureen Legendre; Elizabeth Nelson; Kelly C Drews; Robin Gross; Dawn M Gerhardt; Lisa Torzewski; Elena Postnikova; Janie Y Liang; Bhupal Ban; Jagathpala Shetty; Lisa E Hensley; Peter B Jahrling; Gene G Olinger; Judith M White; David M Markovitz
Journal:  PLoS Negl Trop Dis       Date:  2019-07-29

Review 5.  Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens.

Authors:  Anahita Fathi; Christine Dahlke; Marylyn M Addo
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

Review 6.  Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection.

Authors:  Stephanie Longet; Jack Mellors; Miles W Carroll; Tom Tipton
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

7.  Ethical considerations for epidemic vaccine trials.

Authors:  Joshua Teperowski Monrad
Journal:  J Med Ethics       Date:  2020-05-15       Impact factor: 2.903

Review 8.  [Epidemic and emerging prone-infectious diseases: Lessons learned and ways forward].

Authors:  Denis Malvy; Bernard-Alex Gaüzère; René Migliani
Journal:  Presse Med       Date:  2019-11-26       Impact factor: 1.228

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.